Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Cell Death & Disease|June 27, 2018
NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's DiseaseRossana Sirabella, Maria Josè Sisalli, Giulia Costa, et al.
Experimental Neurology|January 28, 2024
Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's diseaseMargherita Tassan Mazzocco, Marcello Serra, Marco Maspero, et al.
Psychoneuroendocrinology|August 24, 2010
Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activityBarbara Costa, Eleonora Da Pozzo, Beatrice Chelli, et al.
Neurorehabilitation|June 8, 2012
Rehabilitation improves dyskinesias in Parkinsonian patients: a pilot study comparing two different rehabilitative treatmentsGiuseppe Frazzitta, Gabriella Bertotti, Micaela Morelli, et al.
Cells|March 12, 2025
A2A Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson's DiseaseAndrea Spinaci, Michela Buccioni, Diego Dal Ben, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 13, 2016
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's diseaseAnnalisa Pinna, Wai Kin D Ko, Giulia Costa, et al.
Frontiers in Aging Neuroscience|June 2, 2020
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson's DiseaseGiulia Costa, Maria Jose Sisalli, Nicola Simola, et al.
Chemical Senses|April 5, 2019
Odor Identification Performance in Idiopathic Parkinson's Disease Is Associated With Gender and the Genetic Variability of the Olfactory Binding ProteinMelania Melis, Giorgia Sollai, Carla Masala, et al.
Frontiers in Pharmacology|September 13, 2021
Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related DifferencesGiulia Costa, Francesca Felicia Caputi, Marcello Serra, et al.
Journal of Parkinson'S Disease|February 10, 2024
Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and DyskinesiaRossella Cirillo, Sandra Duperrier, Pathik Parekh, et al.
Pageof 12